Carlos Schuler Email

Chief Technology Officer and Co-founder . InCarda Therapeutics

Current Roles

Employees:
26
Revenue:
$2M
About
InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).
InCarda Therapeutics Address
39899 Balentine Dr
Newark, CA
United States
InCarda Therapeutics Email